TVAHF(TVAHF)
TVAHF
No analyst ratings available
No analyst price targets available for TVAHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $340.15B | $349.90B | $357.58B | $363.05B | $369.70B |
| Low | $327.59B | $340.28B | $346.08B | $351.38B | $357.82B |
| High | $346.87B | $356.76B | $364.61B | $370.19B | $376.97B |
| EBITDA Avg | $31.20B | $32.09B | $32.80B | $33.30B | $33.91B |
| Low | $30.05B | $31.21B | $31.74B | $32.23B | $32.82B |
| High | $31.81B | $32.72B | $33.44B | $33.95B | $34.57B |
| EBIT Avg | $20.24B | $20.82B | $21.27B | $21.60B | $22.00B |
| Low | $19.49B | $20.25B | $20.59B | $20.91B | $21.29B |
| High | $20.64B | $21.23B | $21.69B | $22.02B | $22.43B |
| Net Income Avg | $23.33B | $24.97B | $26.40B | $25.96B | $27.28B |
| Low | $22.36B | $23.92B | $25.30B | $24.88B | $26.14B |
| High | $23.93B | $25.60B | $27.07B | $26.63B | $27.98B |
| EPS Avg | $231.58 | $247.78 | $262.02 | $257.68 | $270.80 |
| Low | $221.90 | $237.43 | $251.07 | $246.91 | $259.48 |
| High | $237.50 | $254.12 | $268.72 | $264.27 | $277.72 |
| Analysts (Rev / EPS) | 5 / 1 | 4 / 1 | 3 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $83.48B | $90.33B | $87.15B |
| Low | $81.52B | $88.21B | $85.10B |
| High | $86.03B | $93.10B | $89.82B |
| EBITDA Avg | $7.66B | $8.29B | $7.99B |
| Low | $7.48B | $8.09B | $7.81B |
| High | $7.89B | $8.54B | $8.24B |
| EBIT Avg | $4.97B | $5.37B | $5.19B |
| Low | $4.85B | $5.25B | $5.06B |
| High | $5.12B | $5.54B | $5.34B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 3 / — | 2 / — | 1 / — |